Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
73
IVSBF Quote, Financials, Valuation and Earnings
Last price:
$40.70
Seasonality move
:
3.22%
Day range:
$40.70 - $40.70
52-week range:
$25.31 - $41.25
Dividend yield:
1.34%
P/E ratio:
7.52x
P/S ratio:
8.70x
P/B ratio:
1.21x
Volume:
633
Avg. volume:
8.9K
1-year change:
35.62%
Market cap:
$124.7B
Revenue:
$8.3B
EPS (TTM):
$5.41
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.3B | $7B | $6.6B | $7.5B | $8.3B | |
| Revenue Growth (YoY) | 38.33% | -4.84% | -5.71% | 13.8% | 10.2% | |
| Cost of Revenues | $2.8B | $3.3B | $3.6B | $3.6B | $3.5B | |
| Gross Profit | $4.5B | $3.7B | $3B | $3.9B | $4.7B | |
| Gross Profit Margin | 61.39% | 52.61% | 45.86% | 51.78% | 57.27% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $1.4B | $797.8M | -$62.2M | $66.2M | -- | |
| Operating Expenses | -$22.2B | $10.3B | -$9.3B | -$7.4B | -$11.7B | |
| Operating Income | $26.7B | -$6.6B | $12.3B | $11.3B | $16.4B | |
| Net Interest Expenses | $244.6M | $246M | $327.1M | $438.5M | $557.4M | |
| EBT. Incl. Unusual Items | $26.3B | -$7.2B | $12B | $10.8B | $16.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $41.6M | $106.6M | $81.8M | $115.1M | $112.9M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$11.6M | -$8M | -$21.4M | -$16M | -$15.7M | |
| Net Income to Common Excl Extra Items | $26.6B | -$7.4B | $11.9B | $10.7B | $16B | |
| Basic EPS (Cont. Ops) | $8.67 | -$2.41 | $3.91 | $3.50 | $5.24 | |
| Diluted EPS (Cont. Ops) | $8.67 | -$2.41 | $3.91 | $3.50 | $5.24 | |
| Weighted Average Basic Share | $3.1B | $3.1B | $3.1B | $3.1B | -- | |
| Weighted Average Diluted Share | $3.1B | $3.1B | $3.1B | $3.1B | -- | |
| EBITDA | $27.1B | -$6.2B | $12.9B | $11.8B | -- | |
| EBIT | $26.7B | -$6.6B | $12.3B | $11.3B | $16.4B | |
| Revenue (Reported) | $7.3B | $7B | $6.6B | $7.5B | $8.3B | |
| Operating Income (Reported) | $26.7B | -$6.6B | $12.3B | $11.3B | $16.4B | |
| Operating Income (Adjusted) | $26.7B | -$6.6B | $12.3B | $11.3B | $16.4B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $10.4B | $6.2B | $1.7B | $1.8B | $2B | |
| Revenue Growth (YoY) | 480.92% | -40.12% | -73.42% | 7.23% | 14.71% | |
| Cost of Revenues | $694.5M | $751.9M | $804.6M | $788.8M | $935.5M | |
| Gross Profit | $9.7B | $5.5B | $852.6M | $988M | $1.1B | |
| Gross Profit Margin | 93.33% | 87.94% | 51.45% | 55.6% | 54.1% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $423.7M | $440.2M | -$4.7B | $3.7B | -$5B | |
| Operating Income | $9.3B | $5B | $5.5B | -$2.7B | $6.1B | |
| Net Interest Expenses | $128.7M | $72.1M | $92.9M | $127.5M | $177.4M | |
| EBT. Incl. Unusual Items | $9.2B | $5B | $5.6B | -$2.9B | $5.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $14M | $51.3M | -$20.6M | $31.9M | $36.5M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$789.9K | $3.5M | -$10.6M | -$1.6M | -$10.4M | |
| Net Income to Common Excl Extra Items | $9.2B | $4.8B | $5.6B | -$2.9B | $5.9B | |
| Basic EPS (Cont. Ops) | $2.99 | $1.57 | $1.83 | -$0.96 | $1.92 | |
| Diluted EPS (Cont. Ops) | $2.99 | $1.57 | $1.83 | -$0.96 | $1.92 | |
| Weighted Average Basic Share | $3.1B | $3.1B | $3.1B | $3.1B | -- | |
| Weighted Average Diluted Share | $3.1B | $3.1B | $3.1B | $3.1B | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $9.3B | $5B | $5.5B | -$2.7B | $6.1B | |
| Revenue (Reported) | $10.4B | $6.2B | $1.7B | $1.8B | $2B | |
| Operating Income (Reported) | $9.3B | $5B | $5.5B | -$2.7B | $6.1B | |
| Operating Income (Adjusted) | $9.3B | $5B | $5.5B | -$2.7B | $6.1B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $30.9B | -$3B | $9.5B | $7.5B | $14.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.6B | $2.9B | $3B | $3.2B | $3.5B | |
| Gross Profit | $28.3B | -$5.9B | $6.5B | $4.3B | $10.8B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.7B | $1.8B | -$5.9B | -$7.1B | -$6.3B | |
| Operating Income | $26.6B | -$7.7B | $12.4B | $11.4B | $17.1B | |
| Net Interest Expenses | $313.3M | $258.4M | $327M | $438.1M | $536.4M | |
| EBT. Incl. Unusual Items | $26.2B | -$8.2B | $12.1B | $10.9B | $16.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $41.7M | $104.6M | $81.8M | $114.5M | $115.2M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$11.7M | -$8.4M | -$21.4M | -$16M | -$16.2M | |
| Net Income to Common Excl Extra Items | $26.5B | -$8.5B | $12B | $10.8B | $16.6B | |
| Basic EPS (Cont. Ops) | $9.47 | -$2.76 | $3.93 | $3.54 | $5.41 | |
| Diluted EPS (Cont. Ops) | $9.47 | -$2.76 | $3.93 | $3.53 | $5.41 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $26.6B | -$7.7B | $12.4B | $11.4B | $17.1B | |
| Revenue (Reported) | $30.9B | -$3B | $9.5B | $7.5B | $14.3B | |
| Operating Income (Reported) | $26.6B | -$7.7B | $12.4B | $11.4B | $17.1B | |
| Operating Income (Adjusted) | $26.6B | -$7.7B | $12.4B | $11.4B | $17.1B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -$3B | $9.5B | $7.5B | $14.3B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.9B | $3B | $3.2B | $3.5B | -- | |
| Gross Profit | -$5.9B | $6.5B | $4.3B | $10.8B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.8B | -$5.9B | -$7.1B | -$6.3B | -- | |
| Operating Income | -$7.7B | $12.4B | $11.4B | $17.1B | -- | |
| Net Interest Expenses | $258.4M | $327M | $438.1M | $536.4M | -- | |
| EBT. Incl. Unusual Items | -$8.2B | $12.1B | $10.9B | $16.6B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $104.6M | $81.8M | $114.5M | $115.2M | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$8.3M | -$21.4M | -$16M | -$16.2M | -- | |
| Net Income to Common Excl Extra Items | -$8.5B | $12B | $10.8B | $16.6B | -- | |
| Basic EPS (Cont. Ops) | -$2.76 | $3.93 | $3.54 | $5.41 | -- | |
| Diluted EPS (Cont. Ops) | -$2.76 | $3.93 | $3.53 | $5.41 | -- | |
| Weighted Average Basic Share | $12.3B | $12.3B | $12.3B | $9.2B | -- | |
| Weighted Average Diluted Share | $12.3B | $12.3B | $12.3B | $9.2B | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$7.7B | $12.4B | $11.4B | $17.1B | -- | |
| Revenue (Reported) | -$3B | $9.5B | $7.5B | $14.3B | -- | |
| Operating Income (Reported) | -$7.7B | $12.4B | $11.4B | $17.1B | -- | |
| Operating Income (Adjusted) | -$7.7B | $12.4B | $11.4B | $17.1B | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2B | $2.5B | $3.1B | $3B | $2.4B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | $747.4M | $919.7M | $912.6M | $951.4M | $1.2B | |
| Prepaid Expenses | $39.7M | $49.5M | $79.1M | $83.5M | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3.9B | $4.4B | $5.5B | $5.1B | $4.9B | |
| Property Plant And Equipment | $742.9M | $751.4M | $795.5M | $937.6M | $1.9B | |
| Long-Term Investments | $72.4B | $53.9B | $66.3B | $69.7B | $100.1B | |
| Goodwill | $6.1B | $6.1B | $6.4B | $6.5B | -- | |
| Other Intangibles | $3.7B | $3.3B | $3.3B | $3.1B | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $87.9B | $69.5B | $83.2B | $86.5B | $119.6B | |
| Accounts Payable | $464M | $523.6M | $512.8M | $521.1M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.5B | $1.3B | $1.7B | $1.7B | $1.7B | |
| Long-Term Debt | $9.3B | $8.6B | $8.4B | $8.5B | $12.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $12.4B | $11.4B | $12B | $12.3B | $16.2B | |
| Common Stock | $529.6M | $460.2M | $475.8M | $434M | $520.1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $75.4B | $58.1B | $71.1B | $74.2B | $103.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $98.4M | $75.6M | $65.8M | $35.1M | $20.9M | |
| Total Equity | $75.5B | $58.1B | $71.2B | $74.2B | $103.5B | |
| Total Liabilities and Equity | $87.9B | $69.5B | $83.2B | $86.5B | $119.6B | |
| Cash and Short Terms | $2B | $2.5B | $3.1B | $3B | $2.4B | |
| Total Debt | $9.3B | $8.6B | $8.4B | $8.9B | $12.4B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2B | $2.5B | $3.1B | $3B | $2.4B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | $747.4M | $919.7M | $912.6M | $951.4M | $1.2B | |
| Prepaid Expenses | $39.7M | $49.5M | $79.1M | $83.5M | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3.9B | $4.4B | $5.5B | $5.1B | $4.9B | |
| Property Plant And Equipment | $1.6B | $751.4M | $795.5M | $937.6M | $1.9B | |
| Long-Term Investments | $72.2B | $53.9B | $66.3B | $69.7B | $100.1B | |
| Goodwill | $6.1B | $6.1B | $6.4B | $6.5B | -- | |
| Other Intangibles | $3.7B | $3.3B | $3.3B | $3.1B | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $87.9B | $69.5B | $83.2B | $86.5B | $119.6B | |
| Accounts Payable | $464M | $523.6M | $512.8M | $521.1M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.5B | $1.3B | $1.7B | $1.7B | $1.7B | |
| Long-Term Debt | $9.3B | $8.6B | $8.4B | $8.5B | $12.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $12.4B | $11.4B | $12B | $12.3B | $16.2B | |
| Common Stock | -- | $460.2M | $475.8M | $434M | $520.1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $98.4M | $75.6M | $65.8M | $35.1M | $20.9M | |
| Total Equity | $75.5B | $58.1B | $71.2B | $74.2B | $103.5B | |
| Total Liabilities and Equity | $87.9B | $69.5B | $83.2B | $86.5B | $119.6B | |
| Cash and Short Terms | $2B | $2.5B | $3.1B | $3B | $2.4B | |
| Total Debt | $9.3B | $8.6B | $8.4B | $8.9B | $12.4B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.7B | $1.6B | $2B | $2.2B | $2.3B | |
| Capital Expenditures | $453.4M | $431.6M | $350.5M | $418.1M | $323.9M | |
| Cash Acquisitions | $1B | $229.1M | $350.7M | $354.6M | $2.4B | |
| Cash From Investing | -$322.9M | -$737M | $37.6M | -$1.4B | -$3.2B | |
| Dividends Paid (Ex Special Dividend) | $1.2B | $1.2B | $1.3B | $1.4B | $1.6B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $721.1M | $1.3B | $1.3B | $2B | -- | |
| Long-Term Debt Repaid | -$1B | -$1.6B | -$1.4B | -$1.6B | -- | |
| Repurchase of Common Stock | $17.4M | $14.5M | $21.3M | $33.7M | $20.2M | |
| Other Financing Activities | -$116.8K | -- | -- | -$366.5M | -- | |
| Cash From Financing | -$1.5B | -$1.5B | -$1.5B | -$1B | $739.7M | |
| Beginning Cash (CF) | $2B | $1.3B | $1.9B | $1.6B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$156.1M | -$510.4M | $530.4M | -$148.9M | -$322.3M | |
| Ending Cash (CF) | $1.9B | $830.8M | $2.4B | $1.5B | -- | |
| Levered Free Cash Flow | $1.2B | $1.2B | $1.6B | $1.8B | $1.9B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $623.3M | $475.6M | $606.8M | $474.8M | $569.2M | |
| Capital Expenditures | $157.4M | $65.2M | $110M | $158.5M | $80.4M | |
| Cash Acquisitions | $64.7M | $2.1M | $227.8M | $6.1M | $164.5M | |
| Cash From Investing | $340.3M | $147.5M | -$20M | -$649M | -$428.3M | |
| Dividends Paid (Ex Special Dividend) | $345.6M | $285.6M | $315.8M | $305.8M | $486.4M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $236.8M | $123.3M | $509.7M | $110.4M | -- | |
| Long-Term Debt Repaid | -$570M | -$162.7M | -$567.9M | -$74.9M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$1M | -$385.5K | |
| Other Financing Activities | -$116.8K | -$95.4K | $92.7K | $3.8M | -- | |
| Cash From Financing | -$667.8M | -$312.8M | -$371.6M | $92M | -$337M | |
| Beginning Cash (CF) | -- | $1.3B | $1.9B | $1.6B | -- | |
| Foreign Exchange Rate Adjustment | $12M | -$4M | -$48.6M | $31.1M | -$55.2M | |
| Additions / Reductions | $307.8M | $306.3M | $166.6M | -$51.1M | -$251.5M | |
| Ending Cash (CF) | $319.8M | $1.6B | $2B | $1.5B | -- | |
| Levered Free Cash Flow | $465.9M | $410.4M | $496.7M | $316.3M | $488.7M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.7B | $1.6B | $2B | $2.2B | $2.4B | |
| Capital Expenditures | $449.9M | $441.3M | $349.9M | $408.2M | $337.9M | |
| Cash Acquisitions | $1B | $237.9M | $351.1M | $344.3M | $2.5B | |
| Cash From Investing | -$298.5M | -$728.2M | $41.3M | -$1.4B | -$3.4B | |
| Dividends Paid (Ex Special Dividend) | $1.3B | $1.2B | $1.3B | $1.3B | $1.7B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $721.1M | $1.3B | $1.3B | $2B | -- | |
| Long-Term Debt Repaid | -$1B | -$1.6B | -$1.4B | -$1.6B | -- | |
| Repurchase of Common Stock | $17.7M | $14.9M | $21.4M | $32.2M | $21.1M | |
| Other Financing Activities | -$116.8K | -- | -- | -$366.5M | -- | |
| Cash From Financing | -$1.5B | -$1.5B | -$1.5B | -$976.7M | $771.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$137.8M | -$458.7M | $538.5M | -$112.3M | -$335M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.2B | $1.2B | $1.6B | $1.8B | $2B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.6B | $2B | $2.2B | $2.4B | -- | |
| Capital Expenditures | $441.3M | $349.9M | $408.2M | $337.8M | -- | |
| Cash Acquisitions | $237.9M | $351.1M | $344.3M | $2.5B | -- | |
| Cash From Investing | -$728.2M | $41.3M | -$1.4B | -$3.4B | -- | |
| Dividends Paid (Ex Special Dividend) | $1.2B | $1.3B | $1.3B | $1.7B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.3B | $1.3B | $2B | $2.3B | -- | |
| Long-Term Debt Repaid | -$1.6B | -$1.4B | -$1.6B | -$634.8M | -- | |
| Repurchase of Common Stock | $14.9M | $21.4M | $32.2M | $21.1M | -- | |
| Other Financing Activities | -$10 | -- | -$366.5M | -$108.7M | -- | |
| Cash From Financing | -$1.5B | -$1.5B | -$976.7M | $771.5M | -- | |
| Beginning Cash (CF) | $1.3B | $1.9B | $1.6B | -- | -- | |
| Foreign Exchange Rate Adjustment | $78.7M | -$27.7M | $44.1M | -$97.5M | -- | |
| Additions / Reductions | -$458.7M | $538.5M | -$112.3M | -$335M | -- | |
| Ending Cash (CF) | $1.6B | $1.6B | $1.5B | -$125.8M | -- | |
| Levered Free Cash Flow | $1.2B | $1.6B | $1.8B | $2B | -- | |
Related Companies
Get IVSBF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IVSBF
Sector
P/E ratio
7.52x
12.41x
PEG ratio
0.14x
0.32x
P/B ratio
1.21x
1.15x
Price / LTM sales
8.70x
1.85x
Growth Metrics
IVSBF
Sector
Revenue growth
14.71%
5.48%
Earnings growth
300.09%
10.49%
Revenue (5-year growth)
9.25%
8.67%
Earnings forecast
--
$0.64
Profitability
IVSBF
Sector
Profitability FY 2025
$4.7B
--
Return on invested capital
16.63%
5.21%
Return on assets
16.06%
1.03%
Return on equity
18.73%
9.91%
Earnings Date
Last Earnings Date
Jan
22
Next Earnings Date
Jul
16
Estimated Next Earnings Date
Apr
23
Balance Sheet
IVSBF
Sector
Total cash
$2.4B
$406.5M
Short term investments
--
$190.5M
Total assets
$119.6B
$3.1B
Long term debt
$12.4B
$55M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
79
SPHR alert for Feb 14
Sphere Entertainment Co. [SPHR] is down 0.2% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
